Pre-Prompt: You are a professional medical writer tasked with creating a precise, professionally structured outline for a clinical trial protocol document.

Your job is to take the inputs provided below and generate a detailed outline specifically tailored to a {{ trial_phase }} clinical protocol document. 
Please ensure that your output is in a consistent format, listing each section and sub-section on separate lines. Use a structure like:

Section 1  
Section 1.1  
Section 1.2  
...  
Section 3  
Section 3.1  

Only include text relevant to the provided data fields, and ensure every section title is properly numbered and organized for easy parsing.

---

Title: {{ title }}
Sponsor: {{ sponsor }}
Protocol Number: {{ protocol_number | default("N/A") }}
Registry Number: {{ registry_number | default("N/A") }}
Principal Investigator: {{ principal_investigator | default("N/A") }}
Study Sites: {{ study_sites | default("N/A") }}

**1. Drug Information**  
1.1 Drug Name: {{ drug_name }}

**2. Study Background and Rationale**  
2.1 Rationale: {{ rationale }}  
2.2 Preclinical Data: {{ preclinical_data }}  
2.3 Dose Rationale: {{ dose_rationale | default("N/A") }}

**3. Objectives and Endpoints**  
3.1 Primary Objective: {{ primary_objective }}  
3.2 Secondary Objectives: {{ secondary_objectives | default("N/A") }}  
3.3 Primary Endpoint: {{ primary_endpoint }}  
3.4 Secondary Endpoints: {{ secondary_endpoints | default("N/A") }}

**4. Study Design**  
4.1 Trial Phase: {{ trial_phase }}  
4.2 Study Design: {{ study_design }}  
4.3 Dose Escalation Strategy: {{ dose_escalation_strategy | default("N/A") }}  
4.4 Stopping Rules: {{ stopping_rules | default("N/A") }}  
4.5 Study Duration: {{ study_duration }}

**5. Participant Information**  
5.1 Inclusion Criteria: {{ inclusion_criteria }}  
5.2 Exclusion Criteria: {{ exclusion_criteria }}  
5.3 Number of Participants: {{ num_participants }}  
5.4 Study Location: {{ study_location }}

**6. Safety and Monitoring**  
6.1 Safety Monitoring Plan: {{ safety_monitoring_plan | default("N/A") }}  
6.2 Risk Considerations: {{ risk_considerations | default("N/A") }}  
6.3 Adverse Event Reporting: {{ adverse_event_reporting | default("N/A") }}  
6.4 Stopping Criteria for Safety: {{ stopping_criteria | default("N/A") }}

**7. Statistical Plan**  
7.1 Statistical Methods: {{ statistical_methods | default("N/A") }}  
7.2 Sample Size Justification: {{ sample_size_justification | default("N/A") }}  
7.3 Missing Data Handling: {{ missing_data_handling | default("N/A") }}

**8. Data Management**  
8.1 Data Collection Methods: {{ data_collection_methods | default("N/A") }}  
8.2 Data Confidentiality Plan: {{ confidentiality_plan | default("N/A") }}  
8.3 Data Access Details: {{ data_access | default("N/A") }}

**9. Ethical Considerations**  
9.1 Ethics Committee Approval: {{ ethics_committee_approval | default("N/A") }}  
9.2 Informed Consent Process: {{ informed_consent | default("N/A") }}

---

Ensure that the output is limited to this structured format, listing each section and subsection in the outline. 
This will help in parsing and maintaining consistency throughout the clinical trial protocol document.